博瑞医药：股票交易严重异常波动公告

Core Viewpoint - 博瑞医药's stock has experienced a significant decline, with a cumulative drop of 70% over the last 30 trading days, indicating severe abnormal trading fluctuations [2] Company Summary - 博瑞医药 announced that as of September 24, 2025, its closing price was 72.50 yuan per share [2] - The company's latest rolling price-to-earnings (P/E) ratio is 313.01, which is substantially higher than the average P/E ratio of 31.43 for the pharmaceutical manufacturing industry over the past month [2] - The company conducted a self-examination and confirmed that there are no undisclosed significant matters as of the announcement date [2] Industry Summary - The pharmaceutical manufacturing industry has an average rolling P/E ratio of 31.43, highlighting 博瑞医药's significantly elevated valuation compared to its peers [2]